Gefitinib 67184-0531
Product NDC
67184-0531- Manufacturer
- Qilu Pharmaceutical Co., Ltd.
- Dosage Form
- Tablet, Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 13, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA211591
Need to source Gefitinib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Gefitinib | 250 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]
Packaging Options(3)
30 TABLET, COATED in 1 BOTTLE (67184-0531-1)
500 TABLET, COATED in 1 BOTTLE (67184-0531-2)
3 BLISTER PACK in 1 CARTON (67184-0531-3) / 10 TABLET, COATED in 1 BLISTER PACK